AXIM Biotechnologies, Inc. AXIM
0.00 USD 0.00 (-3.03%)
Nov 4, 2026, 12:43 PM EST
0.0032 Day range 0.0032
0.002 52-week range 0.029
- YTD
- -70.91%
- 1 year
- -64.44%
- Market cap
- 1.12M
- YTD return
- -70.91%
- 1-year return
- -64.44%
- Volume
- 44.84K
- Avg volume
- 322.03K
- Open
- 0.0032
- Previous close
- 0.0033
- Day's range
- 0.0032 – 0.0032
- 52-week range
- 0.002 – 0.029
1Y -0.0068 (-68.00%)
News
VIDEO: AXIM Biotechnologies CEO Presents at Benzinga Virtual Healthcare Summit 2024 
AXIM® Biotechnologies' Tear Based Testing Platform Continues to Gain Traction After Successful Clinical Validation 
AXIM® Biotechnologies Partners With Leading Diagnostic Manufacturer Auer Precision to Scale Assay Production 
AXIM® Biotechnologies Receives Notice of U.S. Patent Allowance for Three Separate Patents Including Its Rapid Point of Care Neutralizing Antibody Test 
Update: AXIM® Biotechnologies Starts Shipping Revenue Generating IgE Diagnostic Validation Assays to Customers Nationwide 
AXIM® Biotechnologies Starts Shipping Revenue Generating IgE Diagnostic Validation Assays to Customers Nationwide 
AXIM® Biotechnologies Develops Next Generation of its Rapid Neutralizing Antibody Test for COVID-19 
AXIM® Biotechnologies Appoints Leading US Ophthalmic Surgeon and Researcher Dr. Henry D. Perry to its Medical Advisory Board 
AXIM® Biotechnologies Appoints Senior DED Expert Dr. Laura Periman to its Medical Advisory Board 
AXIM® Biotech Appoints Ophthalmic Industry Veteran Jeff Busby as Senior VP Business Development
Your note
Sign in to keep a note on AXIM — it syncs with the Stock Master app.